Literature DB >> 29758283

TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.

François Kuonen1, Isabelle Surbeck2, Kavita Y Sarin3, Monique Dontenwill4, Curzio Rüegg5, Michel Gilliet2, Anthony E Oro3, Olivier Gaide2.   

Abstract

Basal cell carcinoma (BCC) is the most frequent human cancer and is becoming an important health problem in an aging population. Based on their clinical and histological characteristics, thick BCC are typically divided into low-risk nodular and high-risk infiltrative subtypes, although the underlying mechanisms are poorly understood. We have identified molecular mechanisms that explain the aggressiveness of high-risk infiltrative BCC, with a potential direct clinical impact. In this study, we first show that fibroblasts, transforming growth factor-β, and fibronectin are found preferentially in infiltrative human BCC. This allowed us to develop in vivo models for the study of infiltrative BCC, which in turn let us confirm the role of transforming growth factor-β in inducing peritumoral fibronectin deposition and tumor infiltration. We then show that fibronectin promotes adhesion and migration of BCC cell lines through integrin α5β1-mediated phosphorylation of focal adhesion kinase. Fittingly, both inhibition of integrin α5β1 and phospho-focal adhesion kinase prevent fibronectin-induced migration of BCC cells in vitro as well as BCC infiltration in vivo. Altogether, our results open important insights into the pathogenesis of aggressive infiltrative BCC and identify integrin α5β1 or focal adhesion kinase inhibition as promising strategies for the treatment of advanced BCC.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29758283      PMCID: PMC6207534          DOI: 10.1016/j.jid.2018.04.029

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  65 in total

1.  Tumor cell invasiveness correlates with changes in integrin expression and localization.

Authors:  Sabine Maschler; Gerhard Wirl; Herbert Spring; Dorothea V Bredow; Isabelle Sordat; Hartmut Beug; Ernst Reichmann
Journal:  Oncogene       Date:  2005-03-17       Impact factor: 9.867

2.  Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.

Authors:  Audrey Dooley; Xu Shi-Wen; Nima Aden; Thomas Tranah; Nirupa Desai; Christopher P Denton; David J Abraham; Richard Bruckdorfer
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

3.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

Review 4.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

5.  Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy.

Authors:  François Kuonen; Julien Laurent; Chiara Secondini; Girieca Lorusso; Jean-Christophe Stehle; Thierry Rausch; Eveline Faes-Van't Hull; Grégory Bieler; Gian-Carlo Alghisi; Reto Schwendener; Snezana Andrejevic-Blant; René-Olivier Mirimanoff; Curzio Rüegg
Journal:  Clin Cancer Res       Date:  2012-06-18       Impact factor: 12.531

Review 6.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

7.  Isolation and propagation of mouse embryonic fibroblasts and preparation of mouse embryonic feeder layer cells.

Authors:  Anna E Michalska
Journal:  Curr Protoc Stem Cell Biol       Date:  2007-10

8.  TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.

Authors:  Carla Cicchini; Ilaria Laudadio; Franca Citarella; Marco Corazzari; Corinna Steindler; Alice Conigliaro; Antonio Fantoni; Laura Amicone; Marco Tripodi
Journal:  Exp Cell Res       Date:  2007-09-18       Impact factor: 3.905

9.  A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth.

Authors:  K K Wary; A Mariotti; C Zurzolo; F G Giancotti
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

Review 10.  The complexities of breast cancer desmoplasia.

Authors:  R A Walker
Journal:  Breast Cancer Res       Date:  2001-02-01       Impact factor: 6.466

View more
  12 in total

Review 1.  Mechanobiology in the Comorbidities of Ehlers Danlos Syndrome.

Authors:  Shaina P Royer; Sangyoon J Han
Journal:  Front Cell Dev Biol       Date:  2022-04-25

Review 2.  TGFβ Signaling in Photoaging and UV-Induced Skin Cancer.

Authors:  Yao Ke; Xiao-Jing Wang
Journal:  J Invest Dermatol       Date:  2021-01-07       Impact factor: 8.551

Review 3.  Fibrosis: Shared Lessons From the Lens and Cornea.

Authors:  A Sue Menko; Janice L Walker; Mary Ann Stepp
Journal:  Anat Rec (Hoboken)       Date:  2019-03-18       Impact factor: 2.064

4.  Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.

Authors:  Ling Lu; Ruting Xie; Rong Wei; Chunmiao Cai; Dexi Bi; Dingzi Yin; Hu Liu; Jiayi Zheng; Youhua Zhang; Feifei Song; Yaohui Gao; Linhua Tan; Qing Wei; Huanlong Qin
Journal:  Mol Oncol       Date:  2019-11-06       Impact factor: 6.603

5.  c-FOS drives reversible basal to squamous cell carcinoma transition.

Authors:  François Kuonen; Nancy Yanzhe Li; Daniel Haensel; Tiffany Patel; Sadhana Gaddam; Laura Yerly; Kerri Rieger; Sumaira Aasi; Anthony E Oro
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.423

6.  Canonical TGFβ signaling induces collective invasion in colorectal carcinogenesis through a Snail1- and Zeb1-independent partial EMT.

Authors:  Marion Flum; Severin Dicks; Yu-Hsiang Teng; Monika Schrempp; Alexander Nyström; Melanie Boerries; Andreas Hecht
Journal:  Oncogene       Date:  2022-01-24       Impact factor: 8.756

Review 7.  Integrin-Mediated Tumorigenesis and Its Therapeutic Applications.

Authors:  Qingling Li; Ting Lan; Jian Xie; Youguang Lu; Dali Zheng; Bohua Su
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

Review 8.  Fibronectin in Cancer: Friend or Foe.

Authors:  Tsung-Cheng Lin; Cheng-Han Yang; Li-Hsin Cheng; Wen-Tsan Chang; Yuh-Rong Lin; Hung-Chi Cheng
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

9.  Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells.

Authors:  Marta Mascaraque; Pablo Delgado-Wicke; Cristina Nuevo-Tapioles; Tamara Gracia-Cazaña; Edgar Abarca-Lachen; Salvador González; José M Cuezva; Yolanda Gilaberte; Ángeles Juarranz
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

10.  Glycoproteomic Analysis Reveals Aberrant Expression of Complement C9 and Fibronectin in the Plasma of Patients with Colorectal Cancer.

Authors:  Juthamard Chantaraamporn; Voraratt Champattanachai; Amnart Khongmanee; Chris Verathamjamras; Naiyarat Prasongsook; Kanokwan Mingkwan; Virat Luevisadpibul; Somchai Chutipongtanate; Jisnuson Svasti
Journal:  Proteomes       Date:  2020-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.